The PennZone

  • Home
  • Business
  • Health
  • Technology
  • Non-profit
  • Automotive
  • Financial
  • Music
  • Entertainment

Olympus Acquires Veran Medical Technologies, Inc.
The PennZone/10102444

Trending...
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 147
  • Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
  • ToneWell Launches AI Wellness Platform with 30-Second Voice-Based Performance Readiness Scan™
CENTER VALLEY, Pa. and TOKYO, Dec. 30, 2020 /PRNewswire/ -- Olympus Corporation today announced that it has finalized the acquisition of Veran Medical Technologies, Inc. (VMT), a leading provider of advanced medical devices specializing in interventional pulmonology, following the definitive agreement the two companies signed December 4, 2020. With this acquisition by Olympus subsidiary Olympus Corporation of the Americas (OCA), Olympus gains VMT's global sales network, marketing, manufacturing, R&D, and other functions to expand the Olympus respiratory product portfolio.

Lung cancer is the leading cause of cancer-related deaths globally.1 With increased awareness and more lung cancer screenings using low-dose computed tomography (CT), the need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase. VMT's SPiN Thoracic Navigation System® and related devices are specifically designed to help physicians navigate to, localize, and sample peripheral pulmonary lesions. Together with the existing Olympus respiratory portfolio that includes radial endobronchial ultrasound (EBUS) and thin bronchoscopes, VMT's navigational system and related devices provide a powerful combination of imaging, access and precision for pulmonologists seeking to diagnose and determine the stage of a patient's lung cancer.

More on The PennZone
  • Star Sleep & Wellness Expands to Pearland, Texas — Bringing Life-Changing Sleep Care to More Communities
  • Fort Lauderdale Dentist Dr. Taskonak & IN A DAY SMILE Receive Emmy Nomination for Life-Changing Documentary "The Weight of a Smile"
  • Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
  • BET and Soul Train Awards - GONE! - Introducing The World Hip Hop Awards
  • Australian Aboriginal Cultural Immersions and First Nations Workshops

"We are very excited about the synergies this acquisition creates. With the deal now closed, as one company we are able to combine Olympus' expertise and clinical history in minimally invasive technology with the innovation in navigation systems of Veran Medical Technology to improve workflow and patient care in lung cancer," said Lynn Ray, Vice President and General Manager of the Global Respiratory Business Unit for Olympus Corporation. "Olympus is committed to providing the medical community with the best tools possible to use in their fight against cancer. With the advent of EBUS-guided transbronchial needle aspiration (EBUS-TBNA) in 2004, Olympus brought patients the benefit of more accurate diagnosis and staging, to improve patient outcomes and care. We are thrilled to be at the forefront of development in this rapidly evolving area of respiratory care."

The acquisition will provide immediate incremental revenue and an experienced sales team within the U.S. market. VMT's advanced and proven navigation technology, together with Olympus' respiratory portfolio, strengthens and enhances Olympus' global position as a medical technology innovator.

As part of its current Corporate Strategy, Olympus vowed to "focus and scale" its Therapeutic solutions Division (TSD). To accelerate the process and provide greater agility, Olympus made OCA the TSD headquarters, recognizing the significant growth opportunities in North America. Olympus also identified three core medical fields to prioritize and has since focused on gastroenterological endotherapy devices, urological devices, and respiratory devices. The VMT acquisition is centered on respiratory devices and will position Olympus as a leader in this field.

More on The PennZone
  • Uk Financial Ltd Featured In New York Business Now — 2019 Gold-Backed Bitcoin Prediction Now Becomes SEC Security Token Filing
  • MROVI Trailer Parts Launches Its Own Tire Brand: Introducing MROVI Tires and the New Didgori Trail Tread
  • AI, Fintech, and Cybersecurity Divisions Ignite High-Margin Growth: IQSTEL, Inc. (N A S D A Q: IQST)
  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders
  • Q4 2025 Outlook: JGCMGS Unveils High-Frequency Infrastructure for Italian and Global Markets

For additional information, please refer to our corporate disclosure, "Notice regarding acquisition of Veran Medical Technologies, Inc. in the United States."

(available at: https://www.olympus-global.com/news/ir/2020/)

1 WHO data:  https://www.who.int/news-room/fact-sheets/detail/cancer

About Olympus' Therapeutic Solutions Division
In its Therapeutic Solutions business, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with its early contributions to the development of the polypectomy snare, Olympus' Therapeutic Solutions portfolio has grown to include an array of surgical energy devices and a wide range of instruments to help prevent, detect, and treat disease. For more information, visit www.olympus-global.com.

SOURCE Olympus

Related Links

http://www.olympus.com/
Filed Under: Business

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
  • Althea Gibson Honored as Final Release in U.S. Mint's American Women Quarters Program
  • ToneWell Launches AI Wellness Platform with 30-Second Voice-Based Performance Readiness Scan™
  • Lokal Media House Achieves Yelp Platinum Partner Status
  • World's First AI-Native Industrial Facility is Under Construction by Carbon AMS with rhobot.ai
  • VIP Vacations Wins Diamon Status with AIC Hotel Group
  • $57 Billion U.S. Marine Industry Presents Major Growth Opportunity for Newly Public Off The Hook Yacht Sales, Inc. (N Y S E: OTH)
  • Deimler Chiropractic Announces Expansion
  • Dr. Alexander Eastman Returns to Suburban Hospital to Deliver Keynote on Crisis Leadership
  • Scoop Social Co.'s Mobile Dessert Truck Business Offer A Lifestyle Of Flavor, Fun, and Freedom
  • Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
  • Lakefront Acreage in Longwood's Ravensbrook Community Hits the Market
  • Monika Balayan Elected Fellow of the Royal Society of Arts (FRSA)
  • Best Companies Group Launches Best Companies to Work for in New York Program
  • We're Winning: Historic Plunge in Overdose Deaths Marks Stunning Reversal in America's Drug Crisis
  • Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2
  • IDI Consulting Spreads Holiday Cheer to Families in Need with 11th Annual Toys for Tots Drive
  • Escajeda Masonry & Concrete Among Pittsburgh's Fastest-Growing Companies
  • New 2025–2026 Energy Rebates: Squeaks Services Explains How to Qualify
  • CCHR's New Documentary Prescription for Violence Highlights Overlooked Safety Warnings

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 149
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 137
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • New Free Science Bingo Cards Help Grade 1 Students Learn Through Play
  • Silver Ball, Golden Heart: Dallas-Area Pinball Wizards Flip for Charity at Side Quest Arcade
  • Revenue Optics Ignites AI Revolution in Industrial Distribution
  • Global Innovators Take the Stage at the WorldUpstart Accelerator Showcase in Philadelphia
  • Passion Struck Network Debuts: A Creator-First Platform for Purpose-Driven Podcasting and Human Impact
  • HR Soul Consulting Recognized as a 2025 Inc. Power Partner Award Winner for the Fourth Consecutive Year

Similar on PennZone

  • 100% Bonus Depreciation Places New Spotlight on Off The Hook Yacht Sales Inc. (N Y S E: OTH) as a Major Player in the $57 Billion U.S. Marine Market
  • AI, Fintech, and Cybersecurity Divisions Ignite High-Margin Growth: IQSTEL, Inc. (N A S D A Q: IQST)
  • Americans Are Building Family Legacies That Last Generations — Not Just Paychecks That Last a Month
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • ProfileSpider Launches Powerful One-Click Profile Scraper for Recruiters and Growth Teams
  • Rio Bela Cosmetics Launches Inclusive Line of Organic Skincare Products
  • The 7 Visibility Problems Costing Independent Hotels Thousands Every Month
  • Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
  • Lokal Media House Achieves Yelp Platinum Partner Status
  • $57 Billion U.S. Marine Industry Presents Major Growth Opportunity for Newly Public Off The Hook Yacht Sales, Inc. (N Y S E: OTH)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us